BRIEF

on Symrise AG (isin : DE000SYM9999)

Symrise Partners with HBC to Enhance Health and Nutrition Offerings

Stock price chart of Symrise AG (EBR:SY1) showing fluctuations.

German company Symrise AG has announced a strategic partnership with Hofseth BioCare (HBC), a Norwegian producer of salmon-based ingredients. This collaboration will enhance Symrise's portfolio in the Human Health and Pet Nutrition markets with clinically validated marine products. HBC, noted for its sustainable marine proteins, collagens, and oils, plans to upgrade its Berkak facility to significantly boost production capacity.

The partnership aims to leverage Symrise's market presence to globalize HBC's products. Symrise CEO, Dr. Jean-Yves Parisot, emphasized the joint initiative's alignment with Symrise's growth strategy in health sectors. HBC's innovative use of salmon offcuts contributes to producing bioactive ingredients with proven health benefits. Jon Olav Odegard from HBC expressed enthusiasm about the collaboration's potential to expand HBC's market access and scale.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Symrise AG news